Safety and Efficacy of Lanreotide Depot Versus Placebo in Neuroendocrine Tumor Patients With a History of Carcinoid Syndrome and Prior Octreotide Therapy Fisher, G. A., Wolin, E. M., Kunz, P., Liyanage, N., Gomez-Panzani, E., Lowenthal, S., Pommier, R. F., Shaheen, M., Vinik, A. NATURE PUBLISHING GROUP. 2015: S1007

View details for Web of Science ID 000363715905053